These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21555737)

  • 1. Copper deficiency myeloneuropathy in a patient with Wilson disease.
    da Silva-Júnior FP; Machado AA; Lucato LT; Cançado EL; Barbosa ER
    Neurology; 2011 May; 76(19):1673-4. PubMed ID: 21555737
    [No Abstract]   [Full Text] [Related]  

  • 2. Recovery after copper-deficiency myeloneuropathy in Wilson's disease.
    Teodoro T; Neutel D; Lobo P; Geraldo AF; Conceição I; Rosa MM; Albuquerque L; Ferreira JJ
    J Neurol; 2013 Jul; 260(7):1917-8. PubMed ID: 23712800
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism.
    Shimizu N; Fujiwara J; Ohnishi S; Sato M; Kodama H; Kohsaka T; Inui A; Fujisawa T; Tamai H; Ida S; Itoh S; Ito M; Horiike N; Harada M; Yoshino M; Aoki T
    Transl Res; 2010 Dec; 156(6):350-7. PubMed ID: 21078496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper deficiency myeloneuropathy: a clue to clioquinol-induced subacute myelo-optic neuropathy?
    Schaumburg H; Herskovitz S
    Neurology; 2008 Aug; 71(9):622-3. PubMed ID: 18725588
    [No Abstract]   [Full Text] [Related]  

  • 5. Axonal sensory motor neuropathy in copper-deficient Wilson's disease.
    Foubert-Samier A; Kazadi A; Rouanet M; Vital A; Lagueny A; Tison F; Meissner W
    Muscle Nerve; 2009 Aug; 40(2):294-6. PubMed ID: 19609919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive outcome in a patient with Wilson's disease treated with reduced zinc dosage in pregnancy.
    Masciullo M; Modoni A; Bianchi ML; De Carolis S; Silvestri G
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):237-8. PubMed ID: 21757286
    [No Abstract]   [Full Text] [Related]  

  • 7. [Zinc acetate hydrate--oral administration (Wilzin)].
    J Pharm Belg; 2009 Sep; (3):107-8. PubMed ID: 19873853
    [No Abstract]   [Full Text] [Related]  

  • 8. Copper deficiency myeloneuropathy due to occult celiac disease.
    Goodman BP; Mistry DH; Pasha SF; Bosch PE
    Neurologist; 2009 Nov; 15(6):355-6. PubMed ID: 19901719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilson disease: copper deficiency and iatrogenic neurological complications with zinc therapy.
    Wu LM; Ekladious A; Wheeler L; Mohamad AA
    Intern Med J; 2020 Jan; 50(1):121-123. PubMed ID: 31943611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to oral supplementation in copper deficiency myeloneuropathy.
    Kelkar P; Chang S; Muley SA
    J Clin Neuromuscul Dis; 2008 Sep; 10(1):1-3. PubMed ID: 18772693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An unrecognized cause of myelopathy associated with copper deficiency: the use of denture cream].
    Trocello JM; Hinfray S; Sanda N; Reiner P; El Balkhi S; Fabre C; Poupon J; Woimant F
    Rev Neurol (Paris); 2011; 167(6-7):537-40. PubMed ID: 21185579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired copper and iron metabolism in blood cells and muscles of patients affected by copper deficiency myeloneuropathy.
    Spinazzi M; Sghirlanzoni A; Salviati L; Angelini C
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):888-98. PubMed ID: 24708542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease.
    Nations SP; Boyer PJ; Love LA; Burritt MF; Butz JA; Wolfe GI; Hynan LS; Reisch J; Trivedi JR
    Neurology; 2008 Aug; 71(9):639-43. PubMed ID: 18525032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of MRI findings of copper deficiency myeloneuropathy in a patient with Wilson's disease.
    Silva-Júnior FP; Machado AA; Lucato LT; Barbosa ER
    Arq Neuropsiquiatr; 2014 Mar; 72(3):255-6. PubMed ID: 24676446
    [No Abstract]   [Full Text] [Related]  

  • 15. Zinc-induced copper deficiency in Wilson disease.
    Horvath J; Beris P; Giostra E; Martin PY; Burkhard PR
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1410-1. PubMed ID: 20921535
    [No Abstract]   [Full Text] [Related]  

  • 16. Good response with zinc acetate monotherapy in an adolescent affected by severe Wilson disease.
    Marazzi MG; Giardino S; Dufour C; Serafino M; Sperlì D; Giacchino R
    Pediatr Med Chir; 2012; 34(2):96-9. PubMed ID: 22730635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloneuropathy and anemia due to copper malabsorption.
    Kumar N; Low PA
    J Neurol; 2004 Jun; 251(6):747-9. PubMed ID: 15311353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper deficiency in celiac disease.
    Halfdanarson TR; Kumar N; Hogan WJ; Murray JA
    J Clin Gastroenterol; 2009 Feb; 43(2):162-4. PubMed ID: 18496230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocupremia-related myeloneuropathy following gastrojejunal bypass surgery.
    Choi EH; Strum W
    Ann Nutr Metab; 2010; 57(3-4):190-2. PubMed ID: 21088385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin: further support for existence of a new zinc overload syndrome.
    Hedera P; Fink JK; Bockenstedt PL; Brewer GJ
    Arch Neurol; 2003 Sep; 60(9):1303-6. PubMed ID: 12975299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.